PharmAla Biotech Provides Corporate Update: U.S. Patent Granted Covering Novel Enantioselective Processes, Decision on APA-01, and Engagement of Canaccord Genuity as Exclusive Investment Banking Partn

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. IONQ
2. IONS
3. AZN
4. SPY
5. NVDA
6. ROIV
7. CRCL
8. AAPL
9. V
10. HOOD

Go back to PharmAla Biotech Provides Corporate Update: U.S. Patent Granted Covering Novel Enantioselective Processes, Decision on APA-01, and Engagement of Canaccord Genuity as Exclusive Investment Banking Partn
(NASDAQ: JUNS) Delayed: 3.27 -0.01 (0.3%)
Previous Close $3.28    52 Week High $ 
Open $3.20    52 Week Low $ 
Day High $3.28    P/E N/A 
Day Low $3.20    EPS $ 
Volume 7,023